×
TELA Bio Pre-Tax Profit Margin 2018-2025 | TELA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
TELA Bio pre-tax profit margin from 2018 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
View More
TELA Bio Pre-Tax Profit Margin 2018-2025 | TELA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
TELA Bio pre-tax profit margin from 2018 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$218.1B
Amgen (AMGN)
$157.3B
Gilead Sciences (GILD)
$135.7B
Vertex Pharmaceuticals (VRTX)
$119.2B
Bristol Myers Squibb (BMY)
$94.5B
CSL (CSLLY)
$78.8B
GSK (GSK)
$77.4B
Regeneron Pharmaceuticals (REGN)
$59.2B
Alnylam Pharmaceuticals (ALNY)
$40.6B
Argenex SE (ARGX)
$34B
BioNTech SE (BNTX)
$26.6B
Royalty Pharma (RPRX)
$20.5B
Insmed (INSM)
$19.5B
Biogen (BIIB)
$18.7B
Illumina (ILMN)
$15.4B
Genmab (GNMSF)
$14.2B
Genmab (GMAB)
$13.6B
Incyte (INCY)
$13.2B
Moderna (MRNA)
$12.2B
Exelixis (EXEL)
$12B
BioMarin Pharmaceutical (BMRN)
$10.9B
Ascendis Pharma (ASND)
$10.7B
QIAGEN (QGEN)
$10.5B
Swedish Orphan Biovitrum (BIOVF)
$10.4B
Exact Sciences (EXAS)
$10B
Verona Pharma American Depositary Share (VRNA)
$8.9B
Blueprint Medicines (BPMC)
$8.4B
Bio-Techne Corp (TECH)
$8.1B
Roivant Sciences (ROIV)
$7.7B
Legend Biotech (LEGN)
$7.3B